GHT Awards 2024 C | Page 41

SUMMIT & AWARDS
HOSPITALS

LEADING FERTILITY INNOVATION & TECHNOLOGY OF THE YEAR IN ASIA-PACIFIC

ALPHA IVF GROUP
Alpha IVF & Women ’ s Specialists : A Beacon of Innovation and Excellence in Fertility Treatment Founded in �011 , Alpha IVF & Women ’ s Specialists is a premier fertility centre located in Kota Damansara , Petaling �aya , Malaysia . Renowned for its cutting-edge technology and exceptional care , Alpha IVF has set new standards in reproductive medicine , transforming the landscape of fertility treatments b oth regionally and worldwide .
Alpha IVF ’ s state-of-the-art facility spans 26 , 221 sq . ft . and offers a comprehensive range of advanced fertility treatments . T hese include IVF ( In-Vitro Fertilization ) with P reimplantation G enetic T esting for Aneuploidy ( P G T -A) , P reimplantation Genetic Testing for Monogenic Diseases ( P G T -M) , and revolutionary Cryotec ® technology for egg and emb ryo freez ing with a consistent 100� post-thaw survival rate . Additional cutting-edge treatments include AI-enhanced embryo selection , Ovarian P latelet-Rich P lasma ( OV A-P RP ) , and E ndometrial P latelet- Rich P lasma ( E ndo-P RP ) .
Alpha IVF ’ s commitment to innovation and excellence is evident in its high IVF success rates of up to �� . �� . This remarkable achievement has garnered international acclaim and validation from esteemed fertility expert Professor Alan Trounson , a world IVF pioneer . P rof . T rounson expressed his profound satisfaction with Alpha IVF during his visit in May 2024 , highlighting their role in advancing fertility treatments . “ I am extremely pleased to be associated with Alpha IVF , � Prof . T rounson stated , emphasiz ing the centre ’ s groundb reaking contrib utions to
Low Sin Yee
reproductive medicine .
Alpha IVF ’ s groundbreaking work in artificial intelligence ( AI ) has further cemented its reputation as a leader in the field . Dato Dr . Colin Lee , Alpha IVF ’ s Medical Director , has been at the forefront of deploying advanced technology for IVF , particularly in the latest application of AI . His expertise and pioneering contrib utions led to his invitation as the keynote speaker at the prestigious PGDIS �0�� conference , where he delivered a keynote on “ AI for E mb ryo Morphology Selection .” T his invitation underscores Alpha IVF ’ s status as a trailb laz er in integrating the latest AI technology with fertility treatments , pushing the b oundaries of what is possib le in reproductive medicine .
T he centre ’ s commitment to excellence is further demonstrated b y its international scientific board , composed of some of the most respected pioneers and icons of IVF . This distinguished b oard includes P rof . Alan T rounson , Bruno Lunenfeld , �ohn Keith , and Michelle P erugini . T heir decision to join
Alpha IVF ’ s international scientific board is a testament to their endorsement of Alpha IVF Group as leaders and innovators in IVF .
Alpha IVF ’ s excellence has been recogniz ed with numerous awards . T he centre received the Frost & Sullivan ’ s �01� Malaysia Fertility Centre of the Y ear award and has b een named Asia- Pacific Fertility Service Provider of the �ear at the Global Health Asia-Pacific Awards multiple times , from 201 9 to 2024 .
Certified by the Reproductive T echnology Accreditation Committee ( RTAC ), Alpha IVF adheres to the highest standards of practice . T hese endorsements ensure that patients receive safe , effective , and ethical treatments , while focusing on personaliz ed care . T he centre ’ s compassionate team understands the emotional and physical challenges of infertility and is committed to supporting patients every step of the way . By comb ining advanced technology with a patient-centric approach , Alpha IVF helps couples turn their dreams of parenthood into reality .
With a state-of-the-art facility , groundb reaking treatments , and an unparalleled commitment to research and innovation , Alpha IVF continues to set new b enchmarks in reproductive medicine .
GlobalHealthAsiaPacific . com SPECIAL ISSUE | 2024
39